ICU Medical develops disposable medical connection ... accounting for 70% of sales.

In a report released yesterday, Michael Toomey from Jefferies upgraded ICU Medical (ICUI – Research Report) to a Buy, with a price target of ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $197.5, along with a high estimate of $209.00 and a low estimate of $183.00. This current ...

Based on the one-year price targets offered by 5 analysts, the average target price for ICU Medical Inc (NASDAQ:ICUI) is $176.40 with a high estimate of $198 and a low estimate of $140.

ICU Medical, Inc. has a 12-month low of $83.26 and a 12-month high of $196.26. The stock has a market cap of $3.81 billion, a P/E ratio of -34.27 and a beta of 0.62. Insider Transactions at ICU ...

No-moat ICU Medical’s third-quarter results are in ... we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

During the last three months, 4 analysts shared their evaluations of ICU Medical ICUI ... generating over 63% of its sales domestically. Market Capitalization: Exceeding industry standards ...

ICU Medical Stock Performance ICUI stock opened at $163.96 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 1 ...

Guidance for Adjusted EBITDA: Raised to a range of $355 million to $365 million. Guidance for Adjusted EPS: Raised to a range of $5.40 to $5.70 per share. ICU Medical Inc (NASDAQ:ICUI) reported a 7% ...